THE ROLE OF STEATOSIS AND FIBROSIS PARAMETERS IN PREDICTING HEPATOCELLULAR CARCINOMA RECURRENCE IN CHRONIC HEPATITIS B PATIENTS

被引：0
|
作者：
Yin, Ke [1 ]
Song, Yuyun [1 ]
Jin, Rui [1 ]
Liu, Baiyi [1 ]
Wang, Zilong [1 ]
Ren, Yayun [2 ]
Chng, Elaine [2 ]
Li, Jiaojiao [3 ]
Rao, Huiying [1 ]
Wang, Xiaoxiao [1 ]
Liu, Feng [1 ]
机构：
[1] Peking Univ Peoples Hosp, Beijing, Peoples R China
[2] HistoIndex Pte Ltd, Singapore, Singapore
[3] Hangzhou Choutu Technol Co Ltd, Hangzhou, Peoples R China
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
304
引用
收藏
页码：S217 / S218
页数：2
相关论文
共 50 条
  • [31] Hepatitis B: Liver fibrosis and hepatocellular carcinoma
    Lok, A. S. F.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (10-11): : 911 - 915
  • [32] Chronic Hepatitis B and Hepatocellular Carcinoma
    McClune, Amy C.
    Tong, Myron J.
    CLINICS IN LIVER DISEASE, 2010, 14 (03) : 461 - +
  • [33] Association of Interleukin-28B Genotype and Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
    Hodo, Yuji
    Honda, Masao
    Tanaka, Akihiro
    Nomura, Yoshimoto
    Arai, Kuniaki
    Yamashita, Taro
    Sakai, Yoshio
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Sakai, Akito
    Sasaki, Motoko
    Nakanuma, Yasuni
    Moriyama, Mitsuhiko
    Kaneko, Shuichi
    CLINICAL CANCER RESEARCH, 2013, 19 (07) : 1827 - 1837
  • [34] ASSOCIATION OF INTERLEUKIN 28B GENOTYPE AND HEPATOCELLULAR CARCINOMA RECURRENCE IN PATIENTS WITH CHRONIC HEPATITIS C
    Hodo, Yuji
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY, 2011, 54 : 1363A - 1363A
  • [35] Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure
    Lee, I-Cheng
    Chau, Gar-Yang
    Yeh, Yi-Chen
    Chao, Yee
    Huo, Teh-Ia
    Su, Chien-Wei
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    PLOS ONE, 2017, 12 (11):
  • [36] RELATIVELY DECREASED RISK OF HEPATOCELLULAR CARCINOMA RECURRENCE DURING TENOFOVIR TREATMENT IN CHRONIC HEPATITIS B PATIENTS
    Kawaguchi, Kazunori
    Honda, Masao
    Shimode, Tetsuhiro
    Orita, Noriaki
    Nio, Kouki
    Terashima, Takeshi
    Shimakami, Tetsuro
    Arai, Kuniaki
    Yamashita, Taro
    Sakai, Yoshio
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Kaneko, Shuichi
    HEPATOLOGY, 2021, 74 : 492A - 492A
  • [37] Role of Early On-Treatment Serum HBV RNA Declines in Predicting Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B
    Liu, Shi
    Wong, Grace Lai-Hung
    Fan, Rong
    Niu, Junqi
    Ma, Hong
    Liang, Wanying
    Lu, Xingyu
    Xie, Jianping
    Shang, Jia
    Xie, Dongying
    Liu, Yali
    Zhou, Bin
    Xie, Qing
    Peng, Jie
    Gao, Hongbo
    Rao, Huiying
    Chen, Jinjun
    Sheng, Jifang
    Shen, Sheng
    Yang, Song
    Dou, Xiaoguang
    Zhang, Zhengang
    Wong, Vincent Wai-Sun
    Hou, Jinlin
    Sun, Jian
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (02)
  • [38] TREATMENT RESPONSE OF NONINVASIVE FIBROSIS MARKERS PREDICTS HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS B PATIENTS
    Nam, Heechul
    Jang, Jeong Won
    Kwon, Jung Hyun
    Yoo, Sun Hong
    Nam, Soon Woo
    Lee, Sung Won
    Lee, Hae Lim
    Bae, Si Hyun
    Sung, Pil Soo
    Yang, Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Lee, Soon Kyu
    Tak, Kwon Yong
    HEPATOLOGY, 2019, 70 : 294A - 294A
  • [39] A scoring system in predicting the risk of hepatocellular carcinoma in chronic hepatitis B carrier
    Chan, S. L.
    Mo, F.
    Wong, V. W.
    Wong, G. L.
    Loong, H. H.
    Chan, V.
    Chan, A. T.
    Yeo, W.
    Chan, H. L.
    Mok, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 366 - 366
  • [40] Key role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinoma
    Zhang, Xin
    Ding, Hui-Guo
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (09) : 1282 - 1286
12345